0.6936
price up icon0.52%   0.0036
after-market After Hours: .71 0.0164 +2.36%
loading
Azitra Inc stock is traded at $0.6936, with a volume of 140.21K. It is up +0.52% in the last 24 hours and down -14.58% over the past month. Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
See More
Previous Close:
$0.69
Open:
$0.68
24h Volume:
140.21K
Relative Volume:
0.05
Market Cap:
$2.44M
Revenue:
$1.27M
Net Income/Loss:
$-11.28M
P/E Ratio:
-0.0309
EPS:
-22.4496
Net Cash Flow:
$-10.46M
1W Performance:
-11.42%
1M Performance:
-14.58%
6M Performance:
+137.78%
1Y Performance:
+40.40%
1-Day Range:
Value
$0.68
$0.72
1-Week Range:
Value
$0.68
$0.7642
52-Week Range:
Value
$0.1305
$1.40

Azitra Inc Stock (AZTR) Company Profile

Name
Name
Azitra Inc
Name
Phone
203 646 6446
Name
Address
21 Business Park Drive, Branford
Name
Employee
10
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
AZTR's Discussions on Twitter

Compare AZTR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AZTR
Azitra Inc
0.6936 3.73M 1.27M -11.28M -10.46M -22.45
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Azitra Inc Stock (AZTR) Latest News

pulisher
08:38 AM

Why retail investors favor Azitra Inc. stockTrade Volume Summary & Stock Market Timing Techniques - newser.com

08:38 AM
pulisher
05:36 AM

Is a relief rally coming for Azitra Inc. holdersPortfolio Update Summary & Low Risk High Reward Trade Ideas - newser.com

05:36 AM
pulisher
04:42 AM

Custom strategy builders for tracking Azitra Inc.July 2025 Momentum & Risk Managed Investment Entry Signals - newser.com

04:42 AM
pulisher
Oct 12, 2025

Can Azitra Inc. recover in the next quarterWeekly Loss Report & Fast Moving Trade Plans - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

O,R&L Commercial leases 12,030 s/f of biomed-tech space to Azitra - NEREJ

Oct 10, 2025
pulisher
Oct 09, 2025

Why Azitra Inc stock stays undervalued2025 Breakouts & Breakdowns & Real-Time Volume Triggers - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Azitra Inc. stock prediction for this week2025 Major Catalysts & Entry Point Confirmation Signals - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Branford-based biopharma Azitra faces de-listing from NYSE - Hartford Business Journal

Oct 06, 2025
pulisher
Oct 06, 2025

Is Azitra Inc stock prepared for digital transitionWeekly Trade Report & Low Risk Entry Point Guides - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Azitra Inc stock stays on buy listsEarnings Growth Report & Safe Capital Growth Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

News impact scoring models applied to Azitra Inc.Earnings Beat & AI Enhanced Execution Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Azitra Inc Faces NYSE Compliance Deadline Notice - TipRanks

Oct 03, 2025
pulisher
Oct 03, 2025

Azitra receives notice of non-compliance from NYSE American - MSN

Oct 03, 2025
pulisher
Oct 03, 2025

Azitra receives NYSE American non-compliance notice By Investing.com - Investing.com Australia

Oct 03, 2025
pulisher
Oct 03, 2025

Azitra receives NYSE American non-compliance notice - Investing.com

Oct 03, 2025
pulisher
Oct 03, 2025

$4M Equity Threshold: Azitra Receives NYSE Non-Compliance Notice; Plan Due Oct 31, 2025 - Stock Titan

Oct 03, 2025
pulisher
Oct 03, 2025

Azitra Inc.’s ATR-04 Study: A Potential Game-Changer for Rash Treatment - TipRanks

Oct 03, 2025
pulisher
Oct 03, 2025

How Azitra Inc. stock performs during Fed tightening cyclesWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can machine learning forecast Azitra Inc. recoveryTreasury Yields & Fast Gaining Stock Reports - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

How sentiment analysis helps forecast Azitra Inc.2025 Volatility Report & Growth-Oriented Investment Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Azitra (AZTR) Price Target Decreased by 27.99% to 12.23 - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

What analysts say about Azitra Inc stockPortfolio Allocation Tips & We Spotted the Next Tesla – See Inside - earlytimes.in

Sep 30, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 02:04:32 - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 00:42:21 - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Should You Invest in Munoth Financial Services Limited Before Its Next Earnings ReportInstitutional Holding Changes & Reinvest for Maximum Compounding Returns - earlytimes.in

Sep 29, 2025

Azitra Inc Stock (AZTR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):